Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

abrysvo × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Rituximab 1242 Cyclophosphamide 1150 Vincristine 584 Doxorubicin 520 Etoposide 471 Prednisone 447 Cytarabine 424 fludarabine 415 Methotrexate 378 Dexamethasone 358 fludarabine phosphate 345 Lenalidomide 320 Filgrastim 307 Bendamustine Hydrochloride 244 Radiotherapy 242 venetoclax 230 ibrutinib 228 obinutuzumab 209 Melphalan 204 Peripheral Blood Stem Cell Transplantation 197 Granulocyte Colony-Stimulating Factor 181 Gemcitabine 179 Bortezomib 175 Busulfan 164 Whole-Body Irradiation 161 Mycophenolic Acid 148 Magnetic Resonance Spectroscopy 130 Tacrolimus 129 Specimen Handling 128 Calcium Dobesilate 128

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡